Henry Schein (HSIC) Gains from Sales and Divestitures (2010 - 2023)
Henry Schein (HSIC) recorded quarterly Gains from Sales and Divestitures of $387302.0 in Q2 2023, down 31.68% quarter-over-quarter from $566887.0 in Q4 2022, and down 20.89% on a YoY basis from $489549.0 in Q2 2022.
Henry Schein (HSIC) Gains from Sales and Divestitures (2010 - 2023) Analysis & Trends
Henry Schein's Gains from Sales and Divestitures history runs 14 years deep, the most recent figure standing at $387302.0 for Q2 2023.
- In Q2 2023, Gains from Sales and Divestitures fell 20.89% year-over-year to $387302.0; the TTM figure through Apr 2023 stood at $387302.0 (down 20.89% YoY), while the FY2022 annual figure was $566887.0, up 574.87% from the prior year.
- Gains from Sales and Divestitures was $387302.0 for Q2 2023 at Henry Schein, down from $566887.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $566887.0 in Q4 2022 to a low of $78000.0 in Q1 2021.
- Historically, Gains from Sales and Divestitures has averaged $307195.8 across 5 years, with a median of $319000.0 in 2020.
- The sharpest annual moves came in 2021 and 2022: Gains from Sales and Divestitures plunged 72.54% in 2021, then soared 574.87% in 2022.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $339000.0 in 2019, then decreased by 12.09% to $298000.0 in 2020, then plunged by 71.81% to $84000.0 in 2021, then jumped by 574.87% to $566887.0 in 2022, then plunged by 31.68% to $387302.0 in 2023.
- The last three Gains from Sales and Divestitures figures came in at $387302.0 (Q2 2023), $566887.0 (Q4 2022), and $392646.0 (Q3 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 1, 2023 | 387,302.00 |
| Apr 1, 2023 | 387,302.00 |
| Dec 31, 2022 | 566,887.00 |
| Dec 31, 2022 | 566,887.00 |
| Sep 24, 2022 | 392,646.00 |
| Sep 24, 2022 | 392,646.00 |
| Jun 25, 2022 | 501,944.00 |
| Jun 25, 2022 | 501,944.00 |
| Mar 26, 2022 | 489,549.00 |
| Mar 26, 2022 | 489,549.00 |
| Dec 25, 2021 | 84,000.00 |
| Dec 25, 2021 | 84,000.00 |
| Sep 25, 2021 | 84,000.00 |
| Sep 25, 2021 | 84,000.00 |
| Jun 26, 2021 | 266,000.00 |
| Jun 26, 2021 | 266,000.00 |
| Mar 27, 2021 | 78,000.00 |
| Mar 27, 2021 | 78,000.00 |
| Dec 26, 2020 | 298,000.00 |
| Dec 26, 2020 | 298,000.00 |